Home > Financial Ratios > NEULAND LABORATORIES

NEULAND LABORATORIES
Working Capital/Sales

    Back to All Ratios
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

NEULAND LABORATORIES Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Working Capital/Sales(x) 2.193.163.704.375.17

What is the latest Working Capital/Sales ratio of NEULAND LABORATORIES ?

The latest Working Capital/Sales ratio of NEULAND LABORATORIES is 2.19 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar20252.19
Mar20243.16
Mar20233.70
Mar20224.37
Mar20215.17

How is Working Capital/Sales of NEULAND LABORATORIES Trending?

Years Working Capital/Sales % Change
Mar2025 2.19
-30.70
Mar2024 3.16
-14.59
Mar2023 3.7
-15.33
Mar2022 4.37
-15.47
Mar2021 5.17 -

Other Financial Ratios of NEULAND LABORATORIES


Compare Working Capital/Sales ratio of peers of NEULAND LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NEULAND LABORATORIES ₹16,804.4 Cr 2.3% -13.2% 2.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹390,828.0 Cr 1.2% -5.3% -5.6% Stock Analytics
DIVIS LABORATORIES ₹158,227.0 Cr -3.9% -6% 11.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,045.0 Cr 0.9% 3.7% 20.5% Stock Analytics
CIPLA ₹105,961.0 Cr -1.2% -12.6% -6.6% Stock Analytics
DR REDDYS LABORATORIES ₹98,682.5 Cr -3.4% -5.7% 0.3% Stock Analytics


NEULAND LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NEULAND LABORATORIES

2.3%

-13.2%

2.6%

SENSEX

-0.2%

-4.2%

8.4%


You may also like the below Video Courses